The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules

The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules

الملخص: أهداف البحث: النوع ذو الأهمية غير المحددة أو الآفة الجريبية ذات الأهمية غير المحددة هي فئة غير متجانسة في علم الخلايا الشفط بالإبرة الدقيقة ، والتي لا تزال إدارتها مثيرة للجدل. تكمن الأهمية السريرية لهذه المجموعة في استبعاد الأورام الخبيثة. هدفت الدراسة الحالية إلى تحديد مدى صلاحية إرشادات...

Full description

Bibliographic Details
Main Authors:	Saad M. Alqahtani, MD, Saif S. Al-Sobhi, MD, Mohammed A. Alturiqy, MD, Riyadh I. Alsalloum, MD, Hindi N. Al-Hindi, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Journal of Taibah University Medical Sciences
Subjects:	American College of Radiology Thyroid Imaging Reporting and Data System Atypia of undetermined significance/follicular lesion of undetermined significance Bethesda III
Online Access:	http://www.sciencedirect.com/science/article/pii/S1658361222001950

Similar Items

Weighty Matters: The Obesity–Thyroid Nodule Connection Unveiling the Impact of Obesity on Thyroid Cancer Risk
by: Saad M. Alqahtani, et al.
Published: (2023-09-01)

Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis
by: Krzysztof Kaliszewski, et al.
Published: (2022-08-01)

Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management
by: Taner Bayraktaroğlu, et al.
Published: (2023-06-01)

Interobserver variability in diagnosing thyroid fine-needle aspiration cytology using the 2023 Bethesda system for reporting thyroid cytopathology
by: Pratima Manohar Pattar, et al.
Published: (2025-01-01)

Evaluating Postoperative Outcomes and Investigating the Usefulness of EU-TIRADS Scoring in Managing Pediatric Thyroid Nodules Bethesda 3 and 4
by: Aylin Kılınç Uğurlu, et al.
Published: (2024-06-01)

Prevalence of malignancy in thyroid nodules with AUS cytopathology: A retrospective cross-sectional study
by: Abdullah M. Alshalaan, et al.
Published: (2024-09-01)

Risk of malignancy in thyroid nodules classified as Bethesda categories III, III - subcategories and IV: 2.5 years study
by: Abeer M Ilyas, et al.
Published: (2023-01-01)

Cytologic assessment of thyroid nodules – Updates in 2023 Bethesda reporting system, diagnostic challenges and pitfalls
by: Xiaobing Jin, et al.
Published: (2024-06-01)

Atypia of Undetermined Significance in Thyroid Fine-Needle Aspiration Cytology: Pathological Evaluation and Risk Factors for Malignancy
by: Şafak Akın, et al.
Published: (2017-09-01)

Ultrasonographic Characteristics of Thyroid Nodules with Nondiagnostic and Atypia of Undetermined Significance in Fine-Needle Aspiration Cytology
by: Ahmet Bozer, et al.
Published: (2024-05-01)

Optimizing thyroid AUS nodules malignancy prediction: a comprehensive study of logistic regression and machine learning models
by: Yuan Cao, et al.
Published: (2024-11-01)

Intraoperative Assessment of High-Risk Thyroid Nodules Based on Electrical Impedance Measurements: A Feasibility Study
by: Jalil Beheshti Firoozabadi, et al.
Published: (2022-11-01)

Ultrasonographic predictors of thyroid cancer in Bethesda III and IV thyroid nodules
by: Ebtihal Y. Alyusuf, et al.
Published: (2024-02-01)

Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
by: Wen-Hui Chan, et al.
Published: (2024-11-01)

The Role of “Critical” Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules
by: Giuseppina Orlando, et al.
Published: (2023-08-01)

Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results
by: Pi-Ling Chiang, et al.
Published: (2023-10-01)

Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report
by: Tomoaki Haga, et al.
Published: (2024-06-01)

Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations
by: Laura Fugazzola, et al.
Published: (2024-05-01)

Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma
by: Christopher J. Fay, BA, et al.
Published: (2023-10-01)

EVALUATION OF HUMAN IMMUNOGLOBULIN EFFECTIVENESS IN PATIENTS WITH SENSORYMOTOR POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMAPATHY OF UNDETERMINED SIGNIFICANCE
by: A. A. Yakovlev, et al.
Published: (2018-08-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

Antiphospholipid syndrome, monoclonal gammopathy, and cryoglobulinemia overlap leading to recurrent cutaneous microvascular thrombosis: A case report and retrospective cohort study
by: Alexandra Bohm, et al.
Published: (2024-10-01)

Poems syndrome: The rare endocrinopathy
by: Miletić Marija, et al.
Published: (2024-01-01)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy
by: Jennifer Lourdes Ng, et al.
Published: (2023-08-01)

Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing
by: Maria Mavromati, et al.
Published: (2023-10-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Significance of bone marrow immunohistochemical analysis in patients with plasma cell neoplasms
by: Zh. M. Kozich, et al.
Published: (2023-05-01)

Inter-Reader Agreement of ATA Sonographic Risk in Thyroid Nodules with Bethesda Category III Indeterminate Cytology
by: Maria I. Linares Valderrama, et al.
Published: (2021-04-01)

Age Related Cytoarchitectural Comparison of Histopathological Changes in Thyroid Nodule
by: Tanweer Fatima, et al.
Published: (2023-04-01)

Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
by: Alessandra Trojani, et al.
Published: (2024-12-01)

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
by: Anping Xu, et al.
Published: (2024-12-01)

Monoclonal Gammopathies of Undetermined Significance and Abnormal Serum Protein Rates Prevelance in Blood Donors: For Improved Transfusion Safety
by: Marwan Benzouarhia, et al.
Published: (2024-05-01)

The role of nutrition and gut microbiome in the progression of multiple myeloma and its precursor disease
by: Panagiotis T. Kanellos, et al.
Published: (2024-10-01)

Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management
by: Mouhamed Yazan Abou‐Ismail, et al.
Published: (2021-02-01)

Unusual Spherical Bodies in Bone Marrow of a Patient with Monoclonal Gammopathy of Undetermined Significance
by: Habib Moshref Razavi
Published: (2021-06-01)

FINE NEEDLE ASPIRATION CYTOLOGY AS A FIRST LINE INVESTIGATION IN THYROID LESIONS
by: Mandakini M Patel, et al.
Published: (2013-03-01)

Periorbital Purpura: A Key Finding in Identifying Hematological Disorders
by: Ryohei Ono, et al.
Published: (2025-02-01)

Analysis of rare genetic variants in All of Us cohort patients with common variable immunodeficiency
by: Troy von Beck, et al.
Published: (2024-10-01)

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions
by: Valeria Ferla, et al.
Published: (2024-07-01)

Retrospective study on Bethesda Ⅴ thyroid nodule in diagnosis of papillary thyroid carcinoma: retrospective study
by: YAN Shouyi, CHEN Hongbin, ZHANG Liyong, WANG Bo, CAI Shaojun, LIN Siying, ZHAO Wenxin
Published: (2021-11-01)